GATC Health Featured in BioSpace: AI’s Growing Role in De-Risking Drug Development
August 12, 2026 — GATC Health was featured in a new BioSpace article exploring how AI is transforming the economics of drug development and reshaping the capital markets backing the biopharma industry.
In the piece, Chief Business Officer Tyrone Lam discussed how tech-bio companies can accelerate the industry beyond tech’s fail-fast methodology and into preventing failure very early in the process, thus greatly reducing economic risk. He also shared his view that the current wave of AI-driven investment into the biotech industry represents a lasting transformation of the capital markets, reflecting the benefit of more accurately predicting risk with innovative technology platforms.
The article, “With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development,” situates GATC Health among a growing cohort of “tech-bio” companies — including Isomorphic Labs, Generate:Biomedicines, and NewLimit — that are putting computation at the core of how new medicines are discovered and developed.
READ THE FULL ARTICLE HERE.
About GATC
GATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% sensitivity. Trusted by the world’s largest insurance marketplace, biopharma, researchers, and investment partners, GATC Health’s risk prediction product, the Derisq™ AI report, accurately assesses and predicts drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. GATC Health’s AI platform is also generative, creating novel intellectual property, extending pipelines, and optimizing assets. By uniting advanced AI, multiomics, and predictive modeling, GATC Health accelerates breakthroughs and reduces costly late-stage failures to bring safer, more effective therapies to patients worldwide. For more information, visit www.gatchealth.com.
Contact Us
Similar News
GATC Health Takes the Stage at the DIA Global Annual Meeting—Life Sciences’ Largest Event
June 24, 2026 — Last week at the DIA Global Annual Meeting in Philadelphia, GATC Health President Dr. Rahul Gupta joined an estee…
Read more
GATC Health Showcases Digital Twin Innovations at Sanofi
June 25, 2026 — This month, GATC Health had the privilege of participating in a focused, high-level presentation at Sanofi’s Cambridge…
Read more
GATC Health and UC Irvine Announce Landmark PNAS Publication Validating AI-Platform for Opioid Use Disorder Treatment
April 07, 2026 (GLOBE NEWSWIRE) — GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform d…
Read more